Navigation Links
Advancing delirium care through research
Date:2/24/2011

INDIANAPOLIS -- At least seven million hospitalized Americans suffer from delirium each year, however the condition goes unrecognized in more than 60 percent of patients. Even if diagnosed, there is no effective way to treat the condition, which is a growing concern to medical professionals.

Researchers, clinicians, and administrators from across the United States will meet in Indianapolis, June 5 - 7 for "Advancing Delirium Care through Research," the inaugural conference of the American Delirium Society, to discuss current and future research and therapy.

The scientific conference provides the first opportunity to share information on delirium as a threat to the health and independence of older adults. The meeting is hosted by the Regenstrief Institute and the Indiana University School of Medicine.

Delirium is a state of confusion in which the individual has undergone a sudden alteration of mental status. Delirium is not dementia, but individuals with dementia are more susceptible to developing delirium during hospitalization than individuals without dementia.

Many drugs frequently prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma and cardiovascular disease appear to negatively affect the aging brain causing delirium.

"Having delirium prolongs the length of a hospital stay, increases the risk of post-hospitalization transfer to a nursing home, doubles the risk of death, and increases the vulnerability to Alzheimer's disease. We as a scientific community need to commit our research effort to protect the brains of older adults from the burden of delirium and set a goal of reducing the delirium burden by half within the next two decades," said Malaz Boustani, M.D., MPH., Regenstrief Institute investigator and IU School of Medicine associate professor of medicine.

Dr. Boustani is also an IU Center for Aging Research center scientist and the research director of the Indianapolis Discovery Network for Dementia and of the Healthy Aging Brain Center. A geriatrician who has published several research studies on delirium in hospitalized older adults, he is president-elect of the ADS and assumes presidency of the organization at the inaugural meeting.

"Since delirium affects older patients in the ICU, hospital, rehabilitation units and nursing homes, it needs to be monitored like other vital signs. A system should be put in place so that monitoring is routine for older patients," said ADS president James Rudolph, M.D., of Harvard Medical School and Brigham and Women's Hospital.

For vulnerable older adults developing a urinary tract infection or taking an over-the-counter drug with anti-cholinergic effects (including many popular brands of sleeping pills) may lead to delirium. Less vulnerable individuals may require a more major insult, such as a stroke or heart attack, to trigger delirium.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. ACPs response to the IOMs report the future of nursing: Leading change, advancing health
2. Lumenis Announced Today it is Sponsoring the Endometriosis Foundation of America's Symposium 'Advancing the Art and Science of Endometriosis: Stem Cells to Radical Excision Surgery'
3. MessageSolution Releases Enterprise Migration System for GroupWise, Advancing its Technology Leading Position for Enterprise Information Archiving and Migration
4. HIMSS Interoperability Showcase to Feature Hospira MedNet(TM), Demonstrating Interoperability as Key to Advancing Healthcare
5. Advancing Mesothelioma Research
6. Elderly With Dementia, Delirium Confused by ER Visits: Study
7. Anti-Delirium Drug May Harm Critically Ill Patients
8. Nurses will test method for determining if its dementia or delirium
9. Huntingtons disease breakthrough equals hope for patients
10. Research uncovers a secret society connecting through the Internet
11. Many Breakthrough Drugs Come From Publicly Funded Research: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Advancing delirium care through research
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: